Adial Pharmaceuticals Inc... (ADILW)
NASDAQ: ADILW
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM
Adial Pharmaceuticals WT EXP 073123 Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.07M | -2.19M | -2.46M | -6.48M | -1.9M | -1.35M | -843.92K | -2.91M | -2.87M | -3.11M | -3.85M | -2.91M | -5.83M | -4.32M | -4.44M | -4.83M |
Depreciation & Amortization | 141.00 | 142.00 | 141.00 | 141.00 | 141.00 | 141.00 | -15.56K | 15.84K | 15.55K | 15.26K | 14.98K | 14.71K | 16.39K | 12.28K | 13.97K | 12.47K |
Stock-Based Compensation | 180.2K | 188.26K | 202.38K | 225.99K | 355.66K | 268.37K | 737.58K | 459.58K | 734.14K | 557.01K | 1.1M | 983.61K | 883.56K | 1.19M | 843.29K | 1.32M |
Other Working Capital | 296.59K | 252.83K | -254.1K | -104.25K | 185.08K | -284.03K | -517.14K | -136.31K | 574K | -448.85K | -1.03M | -570.31K | 1.05M | -395.31K | 501.94K | 664.75K |
Other Non-Cash Items | 183.82K | 31.02K | 222.47K | 4.81M | 421.3K | 296.43K | 37.9K | 14K | -325K | -75K | 24K | -146K | 1.49M | 274.52K | 38.39K | 679.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | 37.18K | -296.43K | -987.55K | n/a | -502 | n/a | n/a | n/a | -94.08K | n/a | n/a | n/a |
Change in Working Capital | 252.81K | 278.28K | -114.85K | -30.1K | 222.91K | -311.81K | -822.9K | 117.61K | 691.64K | -791.9K | -825.56K | -441.24K | 1.16M | -687.54K | 341.95K | 652.51K |
Operating Cash Flow | -1.45M | -1.69M | -2.15M | -1.63M | -1.22M | -1.39M | -1.89M | -2.3M | -1.75M | -3.4M | -3.53M | -2.5M | -2.37M | -3.53M | -3.2M | -2.84M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -64.6B | n/a | -33.73K | -30.88K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 350K | 350K | 800K | n/a | n/a | n/a | n/a | n/a | 30.59B | n/a | n/a | 30.59K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 350K | 350K | n/a | n/a | n/a | n/a | n/a | n/a | 34.02B | n/a | n/a | -0.00 |
Investing Cash Flow | n/a | n/a | n/a | n/a | 350K | 350K | 800K | n/a | n/a | n/a | n/a | n/a | 30.59K | n/a | -33.73K | -286 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 1.66K | -1.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 3.82M | n/a | -1.66K | 58.00 | n/a | n/a | n/a | 1.86K | n/a | 455K | n/a | n/a | 1.44M |
Financial Cash Flow | n/a | 3.61M | 411.09K | 3.82M | 3.38M | 138.67K | 58.00 | 609.61K | -9.12M | n/a | 1.86K | 9.12M | 1.25M | 5.5M | 2.81M | 4.08M |
Net Cash Flow | -1.45M | 1.92M | -1.74M | 2.2M | 2.51M | -902.33K | -1.09M | -1.69M | -1.75M | -3.4M | -3.53M | 6.63M | -1.12M | 1.97M | -428.06K | 1.24M |
Free Cash Flow | -1.45M | -1.69M | -2.15M | -1.63M | -1.22M | -1.39M | -1.89M | -2.3M | -1.75M | -3.4M | -3.53M | -2.5M | -64.61B | -3.53M | -3.24M | -2.87M |